Stay updated on Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial

Sign up to get notified when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:46:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-04-23T22:19:37.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed descriptions of a clinical study on the investigational drug 177Lu-3BP-227 and the addition of specific cancer types and a new revision number.
    Difference
    28%
    Check dated 2025-04-16T14:46:06.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T09:58:52.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:38:24.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.9%
    Check dated 2025-02-24T21:21:34.000Z thumbnail image

Stay in the know with updates to Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.